AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15492164
Drug: Placebo (BSS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (BSS Sterile Irrigating Solution)
Trial: 7813167
Drug: Simvastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (20 mg/day for six months)
Trial: 7813167
Drug: Probucol (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probucol (500 mg/day for six months)
Trial: 2684107
Drug: Cefotaxime sodium,
RxNorm normalized name: Cefotaxime Sodium, 1 g injectable powder for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime sodium, 3 x 2 g/d, intravenously (n = 11)
Trial: 2684107
Drug: Penicillin G,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Penicillin G, 4 x 5 million U/d (n = 10)
Trial: 2684107
Drug: Cefotaxime and
RxNorm normalized name: cefotaxime and beta-lactamase inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime and Penicillin G
Trial: 1108695
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of cocaine dissolved in 2 ml of saline without adrenaline
Trial: 1108695
Drug: 35 mg
RxNorm normalized name: papain 35 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 35 mg of cocaine
Trial: 1108695
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of cocaine
Trial: 31359734
Drug: Fuyanshu Capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fuyanshu Capsules combined with levofloxacin hydrochloride and metronidazole for 56 days and 14 days respectively
Trial: 31359734
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received Fuyanshu Capsules as its analogue
Trial: 23381958
Drug: ACT-178882 100
RxNorm normalized name: ACT-541468
DrugBank: Daridorexant (DB15031)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ACT-178882 100 mg single dose
Trial: 23381958
Drug: Diltiazem 300
RxNorm normalized name: diltiazem 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem 300 mg once a day for 13 days + ACT-178882 100 mg single dose on day 4
Trial: 21690070
Drug: 4% gelofusine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% gelofusine solution at the rate of 20 ml/kg/h 30 min before the operation
Trial: 21690070
Drug: Lactated Ringers
RxNorm normalized name: lactated ringers
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lactated Ringers solution at 4 ml/kg/h for maintenance of total blood volume
Trial: 19757979
Drug: Biomedical combination
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biomedical combination therapy (diclofenac, methotrexate, and sulfasalazine)
Trial: 19757979
Drug: Biomedical combination
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biomedical combination therapy (diclofenac, methotrexate, and sulfasalazine) with TCM cold pattern
Trial: 19757979
Drug: Biomedical combination
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biomedical combination therapy (diclofenac, methotrexate, and sulfasalazine) with TCM hot pattern
Trial: 9398103
Drug: Digitalis (deslanoside
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digitalis (deslanoside 0.01 mg/kg)
Trial: 7514506
Drug: Hydromorphone PCA
RxNorm normalized name: lauryl PCA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydromorphone PCA (0.1 mg/hr basal infusion, 0.2 mg Q 5 min bolus, max 1.2 mg/hr)
Trial: 7514506
Drug: Conventional analgesic
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional analgesic therapy (CAT) with morphine 2.5 mg iv Q 30 min prn until extubation, followed by meperidine 1 mg/kg im Q 4 hr or acetaminophen 325 mg with codeine 30 mg po (1 or 2 tablets) when oral intake possible
Trial: 31949115
Drug: Gefapixant (doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gefapixant (doses ≥30 mg)
Trial: 31949115
Drug: Gefapixant (doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gefapixant (doses ≥150 mg)
Trial: 28379925
Drug: Medically graded
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medically graded bee honey at 5 g/day
Trial: 28379925
Drug: Medically graded
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medically graded bee honey at 10 g/day
Trial: 28379925
Drug: Medically graded
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medically graded bee honey at 15 g/day
Trial: 28379925
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (0 g/day honey)
Trial: 22229233
Drug: intradermal non-absorbable
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: intradermal non-absorbable suture
Trial: 22229233
Drug: intradermal non-absorbable
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: intradermal non-absorbable double layer suture
Trial: 12970916
Drug: Parenteral nutrition
RxNorm normalized name: parenteral nutrition solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral nutrition (PN) and enteral nutrition (EN) therapies
Trial: 12970916
Drug: Total parenteral
RxNorm normalized name: TPN - total parenteral nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total parenteral nutrition (TPN) via central venous infusion
Trial: 8599322
Drug: 56.3 mmol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 56.3 mmol acetate/L
Trial: 8599322
Drug: 18.7 mmol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 18.7 mmol propionate/L
Trial: 8599322
Drug: 18.7 mmol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 18.7 mmol acetate/L
Trial: 8599322
Drug: 56.3 mmol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 56.3 mmol propionate/L
Trial: 1457388
Drug: 10 mg/ml
RxNorm normalized name: urea 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/ml fluphenazine decanoate formulation
Trial: 1457388
Drug: 25 mg/ml
RxNorm normalized name: hemin 25 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg/ml standard fluphenazine decanoate formulation
Trial: 1457388
Drug: Pre-injection serum
RxNorm normalized name: antirabies serum,equine Injectable Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-injection serum fluphenazine levels in a subgroup of 10 patients
Trial: 6374050
Drug: Doxorubicin-based chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin-based chemotherapy regimens (cyclophosphamide and doxorubicin alone or in combination with methotrexate or cisplatin)
Trial: 6374050
Drug: Doxorubicin-based chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin-based chemotherapy regimens
Trial: 31192908
Drug: Sustained-release oxycodone
RxNorm normalized name: oxycodone Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release oxycodone (tablets, 12 hourly)
Trial: 31192908
Drug: Immediate-release morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release morphine (5 mg initially, hourly)
Trial: 17889760
Drug: Henderson capsule
RxNorm normalized name: Primula hendersonii whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Henderson capsule tension ring (HCTR, Morcher)
Trial: 11441370
Drug: Fluoxetine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (40 mg) in the acute study
Trial: 11441370
Drug: Fluoxetine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (40 mg/d) in the chronic study
Trial: 4570092
Drug: Antimicrobial treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimicrobial treatment and anti-diarrheal agents
Trial: 21868779
Drug: Exenatide (EXE)
RxNorm normalized name: Exenatide
DrugBank: Exenatide (DB01276)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exenatide (EXE) and Insulin glargine (GLAR)
Trial: 16613177
Drug: Reperfusion therapy,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reperfusion therapy, thrombolysis, or percutaneous coronary intervention
Trial: 16613177
Drug: Medical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical treatment with various pharmacological agents
Trial: 10989852
Drug: Fibreoptic intubation
RxNorm normalized name: ADAPTER,INTUBATION CAREFUSION #1820
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibreoptic intubation through the intubating laryngeal mask (Group L)
Trial: 8230517
Drug: Estramustine (560
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estramustine (560 to 700 mg orally per day)
Trial: 8230517
Drug: Mitomycin C
RxNorm normalized name: Mitomycin C
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mitomycin C (15 mg/m2 by intravenous infusion every 6 weeks)
Trial: 3541419
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate slow release 120 mg once a day
Trial: 24983446
Drug: Subcutaneous methotrexate
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Subcutaneous methotrexate (MTX) administration via prefilled autoinjector pen
Trial: 24983446
Drug: Oral methotrexate
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral methotrexate (MTX) administration
Trial: 16268802
Drug: Lanreotide Autogel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lanreotide Autogel 60 mg
Trial: 22703757
Drug: Lanreotide Autogel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lanreotide Autogel 90 mg
Trial: 10769580
Drug: Combined supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined supplements of several antioxidant vitamins
Trial: 9333111
Drug: Itraconazole 200
RxNorm normalized name: itraconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole 200 mg/day for 4 days
Trial: 8403714
Drug: Standard feeding
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard feeding (commercial milkshake taken immediately after injection)
Trial: 8403714
Drug: Feeding of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Feeding of lipid after injection
Trial: 3780286
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg propranolol plus 12.5 mg hydrochlorothiazide twice daily
Trial: 3780286
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg acebutolol plus 25 mg hydrochlorothiazide once daily
Trial: 30369162
Drug: NSAID injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NSAID injection
Trial: 24603353
Drug: AM-101 0.81
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AM-101 0.81 mg/ml
Trial: 24603353
Drug: AM-101 0.27
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AM-101 0.27 mg/ml
Trial: 20466440
Drug: PI-2301 (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PI-2301 (3 mg)
Trial: 20466440
Drug: PI-2301 (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PI-2301 (10 mg)
Trial: 20466440
Drug: PI-2301 (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PI-2301 (1 mg)
Trial: 17678567
Drug: Fish oil/evening
RxNorm normalized name: omega-3/dha/epa/fish oil/evening primrose oil 58 mg-84 mg-291 mg-140 mg ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil/evening primrose oil (FSO/EPO) blend (456 mg DHA/d and 353 mg GLA/d)
Trial: 15972565
Drug: No offer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No offer of antibiotics
Trial: 1856148
Drug: Once-daily dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily dosing regimen
Trial: 1856148
Drug: Twice-daily dosing
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily dosing regimen
Trial: 6136101
Drug: Lodoxamide tromethamine
RxNorm normalized name: Lodoxamide Tromethamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lodoxamide tromethamine 0.01 mg
Trial: 6136101
Drug: Lodoxamide tromethamine
RxNorm normalized name: Lodoxamide Tromethamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lodoxamide tromethamine 0.1 mg
Trial: 10425980
Drug: Intravenous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous lidocaine (100 mg)
Trial: 23021528
Drug: Topical lidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical lidocaine hydrochloride with 1:100,000 epinephrine
Trial: 19898218
Drug: PegIntron (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PegIntron (all doses)
Trial: 17325604
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg Gag/Pol DNA vaccine
Trial: 17325604
Drug: 1.5 mg
RxNorm normalized name: boron 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg Gag/Pol DNA vaccine
Trial: 17325604
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg Gag/Pol DNA vaccine
Trial: 17325604
Drug: Gag/Pol DNA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gag/Pol DNA vaccine (all doses)
Trial: 12973849
Drug: 8-drugs-in-1-day regimen
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 8-drugs-in-1-day regimen
Trial: 10374248
Drug: Banxia Houpo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Banxia Houpo Tang (BHT) 7.5 g per day for four weeks
Trial: 8678102
Drug: Cefepime (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefepime (2 g thrice daily)
Trial: 8678102
Drug: Comparator regimens
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparator regimens (ceftazidime 2 g thrice daily or piperacillin + gentamicin 3 g every 4 hours + 1.5 mg/kg every 8 hours)
Trial: 7082781
Drug: Tablet dosage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet dosage forms (three different tablet products)
Trial: 7082781
Drug: Reference solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference solution
Trial: 19663099
Drug: zhinbiticose (western
FDA approved: no
EMA approved: no
PMDA approved: no
Description: zhinbiticose (western medicine)
Trial: 16085252
Drug: Acetaminophen (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (1000 mg loading dose intrarectally, followed by 650 mg every 4 hours for 48 hours)
Trial: 16085252
Drug: Placebo (loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (loading dose and subsequent doses as a placebo suppository)
Trial: 10702890
Drug: cilostazol 100
RxNorm normalized name: cilostazol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cilostazol 100 mg twice daily for 13 days
Trial: 10702890
Drug: placebo twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo twice daily for 13 days
Trial: 30466484
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (national smoking cessation help line)
Trial: 22226430
Drug: Sequential use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential use of PDT and imiquimod
Trial: 17875242
Drug: Pregabalin (PGB)
RxNorm normalized name: Pregabalin
DrugBank: Pregabalin (DB00230)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Pregabalin (PGB) 150-600 mg/d
Trial: 17875242
Drug: Gabapentin (GBP)
RxNorm normalized name: Gabapentin
DrugBank: Gabapentin (DB00996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gabapentin (GBP) 900-3600 mg/d
Trial: 11836333
Drug: 17beta-estradiol (E2)
RxNorm normalized name: Estradiol-17beta
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 17beta-estradiol (E2) 1 mg orally twice daily
Trial: 7628023
Drug: Systematic i.m.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systematic i.m. morphine regimen calculated from the initial titrated dose
Trial: 7628023
Drug: Initial i.v.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Initial i.v. morphine dose < or = 6 mg followed by paracetamol only
Trial: 7628023
Drug: High-dose or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose or low-dose i.m. morphine regimen
Trial: 8238144
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg of aspirin daily
Trial: 21744200
Drug: Local anesthetic
RxNorm normalized name: Local anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local anesthetic injection
Trial: 23063945
Drug: Nefopam (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nefopam (0.3 mg/kg bolus at induction followed by 0.065 mg/kg/h for 48 hours)
Trial: 23063945
Drug: Nefopam (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nefopam (0.3 mg/kg bolus at end of surgery followed by 0.065 mg/kg/h for 48 hours)
Trial: 19178788
Drug: Decaffeinated coffee
RxNorm normalized name: Coffee bean
DrugBank: Coffee bean (DB10525)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Decaffeinated coffee (9 mg caffeine)
Trial: 11837985
Drug: n-3 PUFA
RxNorm normalized name: 22:6(n-3)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 PUFA (1 g daily)
Trial: 11837985
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (300 mg daily)
Trial: 9624885
Drug: Combined calcium
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined calcium and vitamin D supplementation (500 mg calcium and 700 IU vitamin D daily for 3 years)
Trial: 8048325
Drug: Dental treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dental treatment timeliness by seamen
Trial: 3292597
Drug: Cetamolol 5-10-15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetamolol 5-10-15 mg/d (low dose)
Trial: 3292597
Drug: Cetamolol 15-25-50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetamolol 15-25-50 mg/d (high dose)
Trial: 3292597
Drug: Cetamolol (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetamolol (both doses)
Trial: 29478187
Drug: American ginseng
RxNorm normalized name: American ginseng
DrugBank: Panax quinquefolius whole (DB14296)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: American ginseng (AG) extract 1 g/meal (3 g/day) for 8 weeks
Trial: 28648948
Drug: Prophylactic Cranial
RxNorm normalized name: geranial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic Cranial Irradiation plus Consolidative Radiation Therapy (PCI+cRT)
Trial: 20972950
Drug: Conservative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative treatment without ECT
Trial: 16443517
Drug: High-dose chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose chemotherapy (HDC) with cyclophosphamide, cisplatin, and carmustine followed by autologous hematopoietic support
Trial: 16443517
Drug: No further
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No further therapy (observation arm)
Trial: 16443517
Drug: Salvage high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salvage high-dose chemotherapy (HDC) after partial response to AFM
Trial: 14518596
Drug: Raloxifene (RLX)
DrugBank: Raloxifene (DB00481)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Raloxifene (RLX) 60 mg/day plus Clodronate (CLD) 100 mg i.m. every 10 days
Trial: 1530798
Drug: Fadrozole 1
RxNorm normalized name: Fadrozole
DrugBank: Fadrozole (DB16832)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fadrozole 1 mg/d
Trial: 1530798
Drug: Fadrozole 4
RxNorm normalized name: Fadrozole
DrugBank: Fadrozole (DB16832)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fadrozole 4 mg/d
Trial: 1530798
Drug: Fadrozole (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fadrozole (both doses)
Trial: 6383127
Drug: Buflomedil (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buflomedil (600 mg daily)
Trial: 31254849
Drug: Nasal high
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal high flow (NHF) at 60 l/min
Trial: 30282685
Drug: bovine lactoferrin
RxNorm normalized name: Bovine lactoferrin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bovine lactoferrin (bLF) added to feeds (up to 250 mg/kg/day)
Trial: 17987126
Drug: Flaxseed-derived lignan
RxNorm normalized name: FLAXSEED
DrugBank: Flax seed (DB10708)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flaxseed-derived lignan capsules (360 mg lignan per day)
Trial: 17987126
Drug: Flaxseed-derived lignan
RxNorm normalized name: FLAXSEED
DrugBank: Flax seed (DB10708)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flaxseed-derived lignan capsules
Trial: 15220366
Drug: Structured care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured care patients on atorvastatin (n=783)
Trial: 12365090
Drug: Telmisartan (T)
RxNorm normalized name: Telmisartan
DrugBank: Telmisartan (DB00966)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Telmisartan (T) 40 mg once daily
Trial: 12365090
Drug: Perindopril (P)
DrugBank: Perindopril (DB00790)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Perindopril (P) 4 mg once daily
Trial: 7866482
Drug: Tetrahydroaminoacridine (THA,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetrahydroaminoacridine (THA, tacrine) treatment for 1 year
Trial: 2527537
Drug: Cilazaprilat (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilazaprilat (2 mg intravenous infusion)
Trial: 26787687
Drug: Surotomycin 250
RxNorm normalized name: Surotomycin
DrugBank: Surotomycin (DB12076)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surotomycin 250 mg twice daily for 14 days